2025 HCPCS Code Q9981
Rolapitant, oral, 1 mg
| Notice | HCPCS Q9981 terminated on December 31, 2016. |
| Short Description | Rolapitant, oral, 1mg |
| Product Note | 0187 |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | July 01, 2016 |
| HCPCS Action Effective Date | January 01, 2017 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q0174 - Thiethylperazine maleate10mg
- Q0175 - Perphenazine 4mg oral
- Q0177 - Hydroxyzine pamoate 25mg
- Q0180 - Dolasetron mesylate oral
- Q0181 - Unspecified oral anti-emetic
- Q0220 - Tixagev and cilgav, 300mg
- Q0221 - Tixagev and cilgav, 600mg
- Q0222 - Bebtelovimab 175 mg
- Q0224 - Inj, pemivibart, 4500 mg
- Q0239 - Bamlanivimab-xxxx
- Q0240 - Casirivi and imdevi 600 mg
- Q0243 - Casirivimab and imdevimab
- Q0244 - Casirivi and imdevi 1200 mg
- Q0245 - Bamlanivimab and etesevima
- Q0247 - Sotrovimab
- Q0249 - Tocilizumab for covid-19
- Q0477 - Pwr module pt cable lvad rpl
- Q0478 - Power adapter, combo vad
- Q0479 - Power module combo vad, rep
- Q0480 - Driver pneumatic vad, rep